Clinical Trials Browser

Terminated × Recurrence × Irinotecan × Clear all

NCT02060955 2016-06-06

Randomized Phase 2 Study to Investigate Efficacy of ALECSAT in Patients With GBM Measured Compared to Avastin/Irinotecan

Phase 2 Terminated

Glioblastoma, Recurrence